Prescott Group Capital Management’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Prescott Group Capital Management’s Portfolio NMRD Stock Details NMRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,850	Closed	-$44K	–	269
2018 Q3	$44K	Buy	+1,850	New	+$45.9K	0.01%	203

Other funds holding NMRD

Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAS

WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return

CFGS

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Prescott Group Capital Management's NMRD Position: Q4 2018 in Review

Prescott Group Capital Management sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q4 2018, closing a stake of 1,850 shares — an estimated $44K sold.

Prescott Group Capital Management first reported a position in NMRD in Q3 2018 and held it in 1 quarter. The position peaked at $44K in Q3 2018. 5 funds tracked by Wall St. Rank hold NMRD as of Q4 2018.

Prescott Group Capital Management reported no remaining Nemaura Medical, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Prescott Group Capital Management sold 1,850 Nemaura Medical, Inc. Common Stock shares in Q4 2018, an estimated $44K.
Prescott Group Capital Management first reported a position in Nemaura Medical, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Prescott Group Capital Management's Nemaura Medical, Inc. Common Stock position peaked at $44K in Q3 2018.
5 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q4 2018.

Based on Prescott Group Capital Management's 13F filing for Q4 2018, filed 11 Feb 2019.